Jazz Pharmaceuticals (JAZZ) EBIT (2010 - 2026)
Jazz Pharmaceuticals' quarterly EBIT came in at $336.6 million in Q1 2026, up 702.15% year-on-year from $42.0 million in Q1 2025, and up 32.24% quarter-over-quarter from $254.5 million in Q4 2025.
Jazz Pharmaceuticals has reported EBIT for 17 years, with the latest figure at $336.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 702.15% year-over-year to $336.6 million; the trailing twelve-month figure through Mar 2026 stood at -$37.7 million (down 106.35% YoY), and the FY2025 full-year result was -$430.2 million, down 160.04% from the prior year.
- EBIT for Q1 2026 stood at $336.6 million, up from $254.5 million in the prior quarter.
- The five-year high for EBIT was $336.6 million in Q1 2026, with the low at -$686.4 million in Q2 2025.
- Average EBIT over 5 years is $66.8 million, with a median of $122.5 million recorded in 2023.
- Year-over-year, EBIT plunged 633.39% in 2022 and surged 702.15% in 2026.
- Tracing JAZZ's EBIT over 5 years: stood at -$263.4 million in 2022, then soared by 146.51% to $122.5 million in 2023, then jumped by 55.73% to $190.8 million in 2024, then surged by 33.43% to $254.5 million in 2025, then soared by 32.24% to $336.6 million in 2026.
- The last three EBIT figures came in at $336.6 million (Q1 2026), $254.5 million (Q4 2025), and $57.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 336.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 336.60 Mn |
| Dec 31, 2025 | 254.54 Mn |
| Sep 30, 2025 | 57.51 Mn |
| Jun 30, 2025 | -686.39 Mn |
| Mar 31, 2025 | -55.90 Mn |
| Dec 31, 2024 | 190.77 Mn |
| Sep 30, 2024 | 260.21 Mn |
| Jun 30, 2024 | 199.44 Mn |
| Mar 31, 2024 | 66.21 Mn |
| Dec 31, 2023 | 122.50 Mn |
| Sep 30, 2023 | 172.39 Mn |
| Jun 30, 2023 | 157.64 Mn |
| Mar 31, 2023 | 126.06 Mn |
| Dec 31, 2022 | -263.39 Mn |
| Sep 30, 2022 | 24.76 Mn |
| Jun 30, 2022 | 85.55 Mn |
| Mar 31, 2022 | 87.55 Mn |
| Dec 31, 2021 | 49.38 Mn |
| Sep 30, 2021 | 28.37 Mn |
| Jun 30, 2021 | -69.59 Mn |
| Mar 31, 2021 | 162.12 Mn |
| Dec 31, 2020 | 173.41 Mn |
| Sep 30, 2020 | 196.21 Mn |
| Jun 30, 2020 | 198.13 Mn |
| Mar 31, 2020 | -189.67 Mn |
| Dec 31, 2019 | 61.25 Mn |
| Sep 30, 2019 | 133.10 Mn |
| Jun 30, 2019 | 204.28 Mn |
| Mar 31, 2019 | 133.74 Mn |
| Dec 31, 2018 | 185.06 Mn |
| Sep 30, 2018 | 188.78 Mn |
| Jun 30, 2018 | 153.20 Mn |
| Mar 31, 2018 | 87.81 Mn |
| Dec 31, 2017 | 141.21 Mn |
| Sep 30, 2017 | 86.45 Mn |
| Jun 30, 2017 | 165.04 Mn |
| Mar 31, 2017 | 136.14 Mn |
| Dec 31, 2016 | 165.50 Mn |
| Sep 30, 2016 | 136.25 Mn |
| Jun 30, 2016 | 168.74 Mn |
| Mar 31, 2016 | 121.16 Mn |
| Dec 31, 2015 | 106.63 Mn |
| Sep 30, 2015 | 131.53 Mn |
| Jun 30, 2015 | 153.30 Mn |
| Mar 31, 2015 | 116.76 Mn |
| Dec 31, 2014 | 129.92 Mn |
| Sep 30, 2014 | 58.04 Mn |
| Jun 30, 2014 | 74.29 Mn |
| Mar 31, 2014 | -66.66 Mn |
| Sep 30, 2013 | 100.56 Mn |
| Jun 30, 2013 | 77.07 Mn |
| Mar 31, 2013 | 68.19 Mn |
| Dec 31, 2012 | 67.38 Mn |
| Sep 30, 2012 | 55.30 Mn |
| Jun 30, 2012 | 39.43 Mn |
| Mar 31, 2012 | 35.74 Mn |
| Dec 31, 2011 | 37.66 Mn |
| Sep 30, 2011 | 33.70 Mn |
| Jun 30, 2011 | 33.86 Mn |
| Mar 31, 2011 | 22.60 Mn |
| Dec 31, 2010 | 25.54 Mn |
| Sep 30, 2010 | 14.44 Mn |
| Jun 30, 2010 | 10.58 Mn |